|1.||Bush, Sean P: 6 articles (04/2015 - 02/2004)|
|2.||Lavonas, Eric J: 5 articles (01/2014 - 02/2004)|
|3.||Clark, Richard F: 4 articles (08/2010 - 06/2002)|
|4.||Weant, Kyle A: 3 articles (05/2012 - 03/2010)|
|5.||Schaeffer, Tammi H: 3 articles (02/2012 - 01/2009)|
|6.||Kokko, Jamie: 3 articles (02/2011 - 01/2009)|
|7.||Phan, Tammy H: 2 articles (06/2014 - 07/2013)|
|8.||Walter, Frank G: 2 articles (03/2014 - 06/2002)|
|9.||Chase, Peter B: 2 articles (03/2014 - 06/2002)|
|10.||Dart, Richard C: 2 articles (01/2014 - 02/2011)|
|1.||Snake Bites (Snake Bite)
07/01/2013 - "CroFab has been clinically demonstrated to be most effective when administered within 6 h of snake envenomation, and improved clinical outcomes are correlated with quicker timing of administration. "
04/01/2011 - "Intravenous crotalidae polyvalent immune Fab was effective in patients aged ≥10 years who had minimal or moderate envenomation by a North American crotaline, who presented within 6 hours of the snakebite, and who had progression of the envenomation syndrome, according to the results of two prospective trials. "
10/01/2012 - "Over an 8-year time period at this institution, there were 204 admissions for snakebite of which 82 received CroFab. "
05/01/2012 - "To evaluate the safety and cost-effectiveness of a clinical protocol adopted in June 2006 that included a comprehensive, objective assessment of snake bite envenomations and standardized the use of Crotalidae polyvalent immune Fab antivenom (FabAV). "
02/01/2012 - " Crotalidae polyvalent immune Fab (ovine) (FabAV) is commonly used in the treatment of symptomatic North American crotaline snake envenomation. "
04/01/2007 - "In this pediatric series, CroFab appears safe and effective, despite occasional resistant thrombocytopenia."
07/01/2013 - "In patients bitten by North American rattlesnakes and treated with Crotalidae Polyvalent Immune Fab (Ovine) (FabAV), late hematologic abnormalities-persistent, recurrent, or late, new onset of hypofibrinogenemia, prolonged PT/INR, prolonged PTT, and/or thrombocytopenia beyond 48 h post-envenomation-are common, difficult to manage, and may result in morbidity and mortality are common, difficult to manage, and may result in morbidity and mortality. "
01/01/2011 - "North American rattlesnake envenomations commonly produce defibrination, coagulopathy and/or thrombocytopenia, which may be reversed following treatment with Crotalidae Polyvalent Immune Fab Ovine (FabAV). "
08/01/2010 - "Recurrent signs and symptoms after initial treatment and control of coagulopathy and thrombocytopenia after American pit viper (crotaline) envenomations have been previously described in patients treated with Crotalidae polyvalent immune Fab antivenom (FabAV). "
08/01/2010 - "Recurrent coagulopathy and thrombocytopenia in children treated with crotalidae polyvalent immune fab: a case series."
|3.||Bites and Stings (Sting)
02/01/2004 - "Copperhead bites and Crotalidae polyvalent immune Fab (ovine): routine use requires evidence of improved outcomes."
07/01/2013 - "Continuous IV Crotalidae Polyvalent Immune Fab (Ovine) (FabAV) for selected North American rattlesnake bite patients."
10/01/2012 - "Children who received CroFab were more often associated with bites to the hands and fingers and tended to have more significant envenomations as indicated by longer hospital stays, greater tissue injury, and a tendency to require surgery more often. "
06/01/2002 - "Rational use of crotalidae polyvalent immune Fab (ovine) in the management of crotaline bite."
06/01/2014 - "Fifty-two children (34%) received CroFab, with one allergic reaction. "
08/01/2012 - "Intravenous crotalidae polyvalent immune Fab is generally well tolerated, with acute hypersensitivity reactions being the most commonly occurring adverse event."
04/01/2011 - "Intravenous crotalidae polyvalent immune Fab was generally well tolerated; acute hypersensitivity reactions (e.g. "
04/01/2008 - "Acute hypersensitivity reactions associated with administration of crotalidae polyvalent immune Fab antivenom."
04/01/2007 - "There was only one (4.2%) possible acute allergy to CroFab, and there were no deaths. "
01/01/2009 - "In this porcine model of crotaline envenomation, no differences in limb edema were found between animals treated with SC/IV or IV CroFab when compared to saline controls."
01/01/2009 - "This study was designed to investigate whether the local, subcutaneous injection of Crotaline Fab antivenom (CroFab) at the rattlesnake envenomation site would result in less extremity edema when compared to intravenous (i.v.) antivenom infusion alone. "
|1.||Crotalidae Polyvalent immune Fab
|3.||Ethylene Glycol (Monoethylene Glycol)
|5.||Immunoglobulin G (IgG)
|8.||Opioid Analgesics (Opioids)